Source link : https://www.newshealth.biz/health-news/first-generic-of-once-daily-glp-1-injection-approved-for-diabetes/
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to diet and exercise. This is the second GLP-1 receptor agonist to have a generic, following last month’s approval of generic exenatide (referencing […]
Author : News Health
Publish date : 2024-12-23 20:36:23
Copyright for syndicated content belongs to the linked Source.